Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BIO-key International ( (BKYI) ) just unveiled an update.
BIO-key International said that on May 6, 2026 it was notified by Nasdaq that its shares had not met the $1.00 minimum bid price for the required period and that the company had not filed its Form 10-K for 2025, triggering a decision to delist its stock from the Nasdaq Capital Market. Trading on Nasdaq was scheduled to be suspended after the May 12, 2026 close, with the shares moving to OTC Markets on May 13 under the BKYI ticker, while the company seeks to appeal to a Nasdaq Hearings Panel and work toward regaining compliance.
Management highlighted that, despite the listing setback and the timing issues around a recent 1-for-10 reverse split, BIO-key views its operating position as strengthening, citing rising recurring revenue, an improved cost structure and expectations of achieving profitability in the first half of 2026. For investors, the shift to OTC trading may reduce liquidity and visibility in the near term, even as the company pursues a quick restoration of its Nasdaq listing and emphasizes its longer-term growth and financial targets.
The most recent analyst rating on (BKYI) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on BIO-key International stock, see the BKYI Stock Forecast page.
Spark’s Take on BKYI Stock
According to Spark, TipRanks’ AI Analyst, BKYI is a Neutral.
The score is primarily held down by weak financial performance—ongoing large losses and negative cash flow—along with bearish technicals (below major moving averages). Offsetting factors include improving operational narrative and upbeat near-term guidance from the earnings call, but execution and compliance/reporting risks remain notable.
To see Spark’s full report on BKYI stock, click here.
More about BIO-key International
BIO-key International, Inc. is a global provider of identity and access management and biometric authentication technologies, offering cloud-hosted and on-premise PortalGuard IAM solutions for more than forty million users. The company focuses on biometric-centric, multi-factor authentication, including phoneless, tokenless and passwordless options, to secure access to computers, applications and high-value digital transactions.
Average Trading Volume: 33,864
Technical Sentiment Signal: Sell
Current Market Cap: $5.66M
Find detailed analytics on BKYI stock on TipRanks’ Stock Analysis page.